Stock listing

OTC:RSPI RespireRx Pharmaceuticals Inc Stock

Follow RespireRx Pharmaceuticals Inc into a list and get an email when it puts out news.

Delisted OTC:RSPI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:RSPI
Asset type
Stock
Exchange
OTC
Currency
USD

RespireRx Pharmaceuticals Inc on 6ix

Decks
32 decks · latest Nov 10, 2022

Where RespireRx Pharmaceuticals Inc is listed

ListingExchangeCountryCurrency
OTC:RSPI · This page · DelistedOTCUnited StatesUSD
OTC:RSPID · DelistedOTCUnited StatesUSD

Decks

DeckKindSlidesDate
Investor Summit, November 14-15, 2022Conference32 slidesNov 10, 2022
Investor Presentation (November 2022)Investor deck38 slidesNov 7, 2022
Investor Presentation (September 2022)Investor deck23 slidesSep 13, 2022
Biotech Showcase 2022Conference13 slidesDec 14, 2021
Investor Presentation (December 2021)Investor deck15 slidesDec 14, 2021
Investor Presentation (May 2021)Investor deck18 slidesMay 6, 2021
Investor Presentation (November 2020)Investor deck36 slidesNov 12, 2020
Investor Presentation (March 2020)Investor deck16 slidesMar 9, 2020
Investor Presentation (December 2018)Investor deck26 slidesDec 10, 2018
Cannabinoid summit, Boston, December 10-12, 2018Conference22 slidesDec 10, 2018
All 32 decks
DeckKindSlidesDate
Investor Presentation (December 2018)Investor deck10 slidesDec 10, 2018
Investor Presentation (January 2018)Investor deck39 slidesJan 8, 2018
Investor Presentation (September 2017)Investor deck36 slidesSep 8, 2017
2017 Marcum Microcap ConferenceConference37 slidesJun 16, 2017
Technical Presentation (June 2017)Technical9 slidesJun 6, 2017
BIO CEO & Investor Conference 2017Conference38 slidesFeb 10, 2017
Investor Presentation (January 2017)Investor deck41 slidesJan 6, 2017
Investor Presentation (October 2016)Investor deck41 slidesOct 17, 2016
Investor Presentation (September 2016)Investor deck39 slidesSep 12, 2016
Investor Presentation (July 2016)Investor deck35 slidesJul 13, 2016
Jefferies 2016 Healthcare ConferenceConference36 slidesJun 8, 2016
28th Annual ROTH Conference 2016Conference35 slidesMar 11, 2016
Investor Presentation (February 2016)Investor deck34 slidesFeb 4, 2016
Noble Financial Capital Markets' Twelfth Annual Investor/Equity Conference (NobleCon12) (January 2016)Conference35 slidesJan 19, 2016
Biotech Showcase 2016Conference34 slidesJan 11, 2016
Cortex Pharmaceuticals — Investor Presentation (October 2015)Investor deck34 slidesOct 20, 2015
Cortex Pharmaceuticals — Rodman & Renshaw 17th Annual Global Investment Conference 2015Conference35 slidesSep 8, 2015
Cortex Pharmaceuticals — Investor Presentation (July 2015)Investor deck36 slidesJul 9, 2015
Cortex Pharmaceuticals — Investor Presentation (May 2015)Investor deck5 slidesMay 18, 2015
Cortex Pharmaceuticals — Investor Presentation (May 2015)Investor deck30 slidesMay 1, 2015
Cortex Pharmaceuticals — Biotechnology Showcase 2015Conference33 slidesJan 13, 2015
Cortex Pharmaceuticals — Rodman and Renshaw 16th Annual Global Investment Conference (September 2014)Conference33 slidesSep 5, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Sapirstein
Other companies: INmune Bio Inc. (Director · Since at least Sep 8, 2026); Cocrystal Pharma, Inc. (Chief Executive Officer · Since at least Jun 3, 2026); ZyVersa Therapeutics, Inc. (Director · Since at least Jan 5, 2023); Onconetix, Inc. (Director · Feb 23, 2022 – Sep 26, 2024 · Past); Blue Water Acquisition Corp (Director · Dec 15, 2020 – Dec 15, 2020 · Past); Marizyme, Inc. (Interim CEO, Director · Sep 10, 2020 – Mar 5, 2021 · Past); GridAI Technologies Corp. (Chairman and CEO, Director · Oct 8, 2019 – Jul 2, 2024 · Past); Lunai Bioworks Inc. (Director · Mar 6, 2018 – Jun 25, 2024 · Past); Hepion Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jan 3, 2018 – Jan 3, 2018 · Past)
Director · Dec 9, 2017 – Dec 9, 2017 · Past
James S. Manuso
Other companies: TuHURA Biosciences, Inc. (Chairman of the Board of Directors · Since at least Oct 18, 2024); Opus Genetics, Inc. (Director · Since at least Nov 5, 2020); Astex Pharmaceuticals Inc (Chief Executive Officer, Director · Mar 15, 2010 – Oct 11, 2013 · Past)
President and CEO, Director · Feb 4, 2016 – Sep 13, 2017 · Past
Jeff Eliot MargolisSVP, CFO, Secret'y & Treasurer, Director · Aug 28, 2015 – Sep 30, 2020 · Past
Katie MacFarlaneDirector · Mar 31, 2016 – Sep 30, 2020 · Past
Timothy L JonesCEO and President, Director · Sep 30, 2020 – Sep 30, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about RespireRx Pharmaceuticals Inc.